Hogan Lovells 2024 Election Impact and Congressional Outlook Report
Dr. Alexander Klicznik, Dipl.-Phys.
Partner/Patent Attorney Intellectual Property
Languages
English, German
Alexander Klicznik has been focusing on patents since 1999 (initially in the field of research and teaching at the Max Planck Institute for Intellectual Property in Munich, since 2004 as a German attorney-at-law dedicated to patent litigation, subsequently also as a European Patent Attorney and since 2023 as a representative before the UPC). He is one of the few dual-qualified attorneys/patent attorneys in Germany who is recommended for both infringement actions and nullity actions (IAM Patent 1000; Legal 500).
In addition to litigation, Alexander Klicznik is also a lecturer for nullity proceedings, opposition proceedings and proceedings before the Unified Patent Court in the Intellectual Property LL.M. programme at the University of Düsseldorf.
During his previous studies in physics, Alexander Klicznik worked on magnetic atomic force microscopy on magnetic thin films, NMR spectroscopy and the programming of software to read and analyse an extensive database as part of an experimental determination of the magnetic form factor of the neutron.
Representing North American pharma company in patent infringement proceedings and invalidity proceedings in relation to hemodialysis.
Representing Agilent in the area of mass spectrometry/chromatography in patent infringement proceedings and parallel opposition and nullity proceedings (on the basis of three patents).
Representing French Company asserting patent on method of protein separation aimed at purifying Factor VIII (parallel EPO opposition proceedings, then revocation proceedings).
Representing French manufacturer of contrast agents for several imaging techniques; advice re pending EPO proceedings.
Representing Opponent in EPO opposition relating to production of hemoglobin.
Advising a Japan based pharmaceutical company in opposition proceedings concerning cancer medication.
Representing Northern American Pharma company in Nullity action in the field of vaccines.
Representation in more than 100 opposition proceedings and nullity proceedings.